Search

everythinglearnresearchcommunity

for

Search:↓

PCOS causes sexual dysfunction, needing comprehensive treatment.

Solid lipid nanoparticles are promising for safe and effective drug delivery but need more research for clinical use.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Test thyroid function in all obese patients and prioritize weight loss for hormonal balance.

Oral testosterone therapy raises heart risk more than other methods.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Anabolic androgenic steroids can increase cancer risk and disrupt hormones.

Metabolic syndrome is common in African populations, needing urgent prevention and treatment.

Computer-aided methods can speed up COVID-19 drug discovery and help find new uses for existing drugs.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

Progesterone protects neurons from damage by converting to allopregnanolone, which works through GABAA receptors.

Lifestyle changes, exercise, and antioxidants can help manage polycystic ovary syndrome.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Taking 1 mg of finasteride daily can increase hair count and improve hair appearance, but it may have side effects on sexual function and a potential risk of prostate cancer. It may not be effective for postmenopausal women unless taken in higher doses.

Dutasteride is more effective than finasteride at increasing hair count and reversing hair thinning in men with hair loss, but both have similar side effects.

Male infertility and genitourinary birth defects are often linked to genetic issues.

Botulinum A toxin injections reduced pain and promoted hair regrowth in a woman with a rare form of alopecia areata.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

Swellable microneedles could improve drug delivery and diagnostics but need more research on materials and technology integration.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Changes in SHBG levels don't predict diabetes risk reduction.

BPH treatments are improving with personalized medicine and better surgical options.

New treatments like plant extracts, nanocarriers, and 3D bioprinting show promise for hair loss, but more research is needed.

Research on non-muscle invasive bladder cancer has increased, with the U.S. leading, and highlights effective treatments like BCG despite some side effects.

OnabotulinumtoxinA is used to treat wrinkles, pain, sweating, hair loss, and more by temporarily paralyzing muscles and affecting pain pathways.

Gender affirming hormone therapy improves outcomes in gender affirmation surgery.